Vyhláška Ministerstva zdravotnictví, kterou se mění vyhláška Ministerstva zdravotnictví č. 57/1997 Sb, kterou se stanoví léčivé přípravky plně hrazené ze zdravotního pojištění a výše úhrad jednotlivých léčivých látek, ve znění vyhlášek č. 109/1997 Sb., č. 131/1997 Sb., č. 220/1997 Sb. a č. 317/1997 Sb
| 295 | L01BA | antimetabolity ze skupiny analog kyseliny listové | p.o. | ||||
|---|---|---|---|---|---|---|---|
| 295.1 | L01BA01 | metotrexát | p.o. | 1 | MG | 1,50 | |
| 91065 | METHOTREXAT LACHEMA 2.5 | tbl 100x2.5mg | LCM | CZ | |||
| 91922 | METHOTREXAT LACHEMA 10 | tbl 100x10mg | LCM | CZ | |||
| 296 | L01BA | antimetabolity ze skupiny analog kyseliny listové | parent. | B | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 296.1 | L01BA01 | metotrexát (do 5 mg v jedné ampuli včetně) | parent. | 1 | MG | 8,90 | B |
| 91025 | METHOTREXAT LACHEMA 5 | inj 10x2ml/5mg | LCM | CZ | |||
| 296.2 | L01BA01 | metotrexát (nad 500 mg v jedné ampuli) | parent. | 10 | MG | 4,75 | B |
| 93965 | METHOTREXAT LACHEMA 1000 | inj 10x20ml/1000mg | LCM | CZ | |||
| 296.3 | L01BA01 | metotrexát (od 5 do 500 mg v jedné ampuli včetně) | parent. | 1 | MG | 3,15 | B |
| 87564 | METHOTREXAT LACHEMA 50 | inj sic 10x50mg | LCM | CZ | |||
| 87761 | METHOTREXAT LACHEMA 500 | inj sic 10x500mg | LCM | CZ | |||
| 93963 | METHOTREXAT LACHEMA 20 | inj 10x2ml/20mg | LCM | CZ | |||
| 93964 | METHOTREXAT LACHEMA 50 | inj 10x5ml/50mg | LCM | CZ | |||
| 83484 | METHOTREXAT LEDERLE | inf 1x20ml/500mg | LED | D | |||
| 297 | L01BB | antimetabolity ze skupiny analog purinů | p.o. | L/ONK,HEM | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 297.1 | L01BB02 | merkaptopurin | p.o. | 10 | MG | 7,60 | L/ONK,HEM |
| 94241 | PURI-NETHOL | tbl 25x50mg | BWE | GB | |||
| 297.2 | L01BB03 | tioguanin | p.o. | 10 | MG | 9,55 | L/ONK,HEM |
| 298 | L01BB | antimetabolity ze skupiny analog purinů | parent. | B/ONK,HEM | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 298.1 | L01BB04 | cladribin | parent. | 1 | MG | 904,90 | B/ONK,HEM |
| 44013 | LEUSTATIN. | inj 1x10ml/10mg | OBI | USA | |||
| 44014 | LEUSTATIN. | inj 7x10ml/10mg | OBI | USA | |||
| 298.2 | L01BB05 | fludarabin | parent. | 1 | MG | 139,20 | B/ONK,HEM |
| 77008 | FLUDARA I.V. | inj sic 5x50mg | SAG | D | |||
| 299 | L01BC | antimetabolity ze skupiny analog pyrimidinu | p.o. | L/ONK,HEM | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 299.1 | L01BC | azaribin | p.o. | 1 | MG | 8,70 | L/ONK,HEM |
| 299.2 | L01BC02 | fluorouracil | p.o. | 10 | MG | 1,70 | L/ONK,HEM |
| 10407 | FTORAFUR | cps 100x400mg | MDX | SU | |||
| 300 | L01BC | antimetabolity ze skupiny analog pyrimidinu | parent. | B/ONK,HEM | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 300.1 | L01BC01 | cytarabin (do 100 mg v jedné ampuli včetně) | parent. | 1 | MG | 1,30 | B/ONK,HEM |
| 87829 | ALEXAN (AMPULE) | inj 10x5ml/100mg | MAC | D | |||
| 02532 | ALEXAN (AMPULE) | inj 30x2ml/40mg | MAC | D | |||
| 99483 | ALEXAN (LAHVICKY) | inj 10x5ml/100mg | MAC | D | |||
| 99484 | ALEXAN (LAHVICKY) | inj 30x2ml/40mg | MAC | D | |||
| 300.2 | L01BC01 | cytarabin (nad 100 mg v jedné ampuli) | parent. | 1 | MG | 1,05 | B/ONK,HEM |
| 96990 | ALEXAN (LAHVICKY) | inj 1x20ml/1000mg | MAC | D | |||
| 300.3 | L01BC02 | fluorouracil | parent. | 10 | MG | 2,90 | B/ONK,HEM |
| 84119 | 5-FU LEDERLE | inj 1x20ml/1gm | LED | D | |||
| 86070 | FLUORO-URACIL | inj 5x5ml/250mg | HLR | CH | |||
| 300.4 | L01BC05 | gemcitabin | parent. | 1 | MG | 6,30 | B/ONK,HEM |
| 84336 | GEMZAR 1GM | inj sic 1x1gm | LIL | F | |||
| 84335 | GEMZAR 200MG | inj sic 1x200mg | LIL | F | |||
| 301 | L01CA | vinka alkaloidy a jejich deriváty | parent. | B/ONK,HEM | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 301.1 | L01CA01 | vinblastin | parent. | 1 | MG | 27,15 | B/ONK,HEM |
| 301.2 | L01CA02 | vinkristin | parent. | 1 | MG | 186,80 | B/ONK,HEM |
| 74990 | CITOMID 1MG | inj sic 1x1mg+10ml | LMR | MEX | |||
| 301.3 | L01CA04 | vinorelbin | parent. | 1 | MG | 110,75 | B/ONK,HEM |
| 302 | L01CB | podofylotoxinové deriváty | p.o. | L/ONK,HEM | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 302.1 | L01CB01 | etoposid | p.o. | 1 | MG | 3,95 | L/ONK,HEM |
| 86416 | VEPESID | cps 20x50mg | BMS | D | |||
| 86417 | VEPESID | cps 10x100mg | BMS | D | |||
| 303 | L01CB | podofylotoxinové deriváty | parent. | B/ONK,HEM | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 303.1 | L01CB01 | etoposid | parent. | 1 | MG | 4,20 | B/ONK,HEM |
| 87191 | ETOPOSIDE DELTA WEST | inj 10x5ml/100mg | DWP | AUS | |||
| 86418 | VEPESID | inj 10x5ml/100mg | BMS | D | |||
| 303.2 | L01CB02 | teniposid | parent. | 1 | MG | 6,45 | B/ONK,HEM |
| 304 | L01CD | taxany | parent. | X | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 304.1 | L01CD01 | paclitaxel | parent. | 1 | MG | 191,30 | X |
| 44134 | TAXOL | inj. 1x17ml/100mg | BMS | I | |||
| 76204 | TAXOL | inj. 1x5ml/30mg | BMS | I | |||
| 92494 | TAXOL | inj 10x5ml/30mg | BMS | I | |||
| 76688 | TAXOL | inj. 1x5ml/30mg | BMS | USA | |||
| 76689 | TAXOL | inj. 10x5ml/30mg | BMS | USA | |||
| 304.2 | L01CD02 | docetaxel | parent. | 1 | MG | 335,30 | X |
| 305 | L01DA | aktinomyciny | parent. | B/ONK,HEM | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 305.1 | L01DA01 | daktinomycin | parent. | 1 | MG | 680,10 | B/ONK,HEM |
| 21055 | LYOVAC COSMEGEN | inj sic 1x0.5mg | MSD | USA | |||
| 306 | L01DB | antracykliny a jejich deriváty | p.o. | X | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 306.1 | L01DB06 | idarubicin | p.o. | 1 | MG | 309,15 | X |
| 78812 | ZAVEDOS 5MG | cps 1x5mg | FAR | I | |||
| 78813 | ZAVEDOS 10MG | cps 1x10mg | FAR | I | |||
| 78814 | ZAVEDOS 25MG | cps 1x25mg | FAR | I | |||
| 307 | L01DB | antracykliny a jejich deriváty | parent. | B/ONK,HEM | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 307.1 | L01DB01 | doxorubicin | parent. | 1 | MG | 39,70 | B/ONK,HEM |
| 12663 | DOXORUBICIN EBEWE 10MG | inj 1x5ml/10mg | EBW | A | |||
| 12664 | DOXORUBICIN EBEWE 50MG | inj 1x25ml/50mg | EBW | A | |||
| 94567 | RASTOCIN | inj 10x10mg | PLI | CHO | |||
| 83092 | DOXOLEM 50MG | inj sic 1x50mg | MCI | CZ | |||
| 307.2 | L01DB02 | daunorubicin | parent. | 1 | MG | 19,65 | B/ONK,HEM |
| 96122 | DAUNOBLASTINA | inj sic 1/20mg + sol. | FAR | I | |||
| 307.3 | L01DB03 | epirubicin | parent. | 1 | MG | 47,90 | B/ONK,HEM |
| 83704 | FARMORUBICIN PFS | inj 1x25ml/50mg | PHA | I | |||
| 94373 | FARMORUBICIN RAPID DISSOLUTION | inj 1x50mg | PHA | I | |||
| 94371 | FARMORUBICIN RAPID DISSOLUTION | inj 1x10mg + 5ml sol | PHA | I | |||
| 307.4 | L01DB04 | aklarubicin | parent. | 1 | MG | 19,65 | B/ONK,HEM |
| 307.5 | L01DB05 | zorubicin | parent. | 1 | MG | 19,65 | B/ONK,HEM |
| 307.6 | L01DB06 | idarubicin | parent. | 1 | MG | 770,85 | B/ONK,HEM |
| 307.7 | L01DB07 | mitoxantron | parent. | 1 | MG | 52,55 | B/ONK,HEM |
| 54033 | REFADOR 2MG/ML | inj 1x15ml/30mg | LCM | CZ | |||
| 308 | L01DC | ostatní cytotoxická antibiotika | parent. | B/ONK,HEM | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 308.1 | L01DC01 | bleomycin | parent. | 1 | MG | 65,20 | B/ONK,HEM |
| 03404 | BLEOCIN | inj 1x15mg | NKU | J | |||
| 308.2 | L01DC03 | mitomycin (do 2 mg v jedné ampuli včetně) | parent. | 1 | MG | 86,60 | B/ONK,HEM |
| 308.3 | L01DC03 | mitomycin (nad 2 mg v jedné ampuli) | parent. | 1 | MG | 70,90 | B/ONK,HEM |
| 83440 | MITOMYCIN C KYOWA | inj sic 5x20mg | KYA | J | |||
| 309 | L01XA | platinová cytostatika | parent. | B/ONK,HEM | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 309.1 | L01XA01 | cisplatina | parent. | 1 | MG | 8,00 | B/ONK,HEM |
| 96453 | PLATIDIAM | inj 10x10mg/20ml | LCM | CZ | |||
| 96454 | PLATIDIAM | inj 5x25mg/50ml | LCM | CZ | |||
| 96455 | PLATIDIAM | inj 1x50mg/100ml | LCM | CZ | |||
| 309.2 | L01XA02 | karboplatina (do 50 mg v jedné ampuli včetně) | parent. | 1 | MG | 6,85 | B/ONK,HEM |
| 90777 | CYCLOPLATIN 50 | inj sic 10x50mg | LCM | CZ | |||
| 75010 | CYCLOPLATIN | inj sic 1x5ml/50mg | LCM | CZ | |||
| 309.3 | L01XA02 | karboplatina (nad 50 mg v jedné ampuli) | parent. | 1 | MG | 3,75 | B/ONK,HEM |
| 93665 | CYCLOPLATIN 200 | inj sic 5x200mg | LCM | CZ | |||
| 60924 | CYCLOPLATIN | inj 1x60ml/600mg | LCM | CZ | |||
| 310 | L01XB | methylhydrazinová cytostatika | p.o. | L/ONK,HEM | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 310.1 | L01XB01 | prokarbazin | p.o. | 10 | MG | 2,50 | L/ONK,HEM |
| 01814 | NATULAN | cps 50x50mg | HLR | CH | |||
| 311 | L01XX | ostatní cytostatika | p.o. | L/ONK,HEM,URN | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 311.1 | L01XX05 | hydroxymočovina | p.o. | 0.1 | GM | 2,35 | L/ONK,HEM,URN |
| 95122 | LITALIR | cps 100x500mg | BMS | D | |||
| 311.2 | L01XX11 | estramustin | p.o. | 10 | MG | 4,00 | L/ONK,HEM,URN |
| 08921 | ESTRACYT | cps 100x140mg | KBP | S | |||
| 311.3 | L01XX14 | tretinoin | p.o. | 10 | MG | 107,25 | L/ONK,HEM,URN |
| 84009 | VESANOID | cps 100x10mg | HLR | CH | |||
| 312 | L01XX | ostatní cytostatika | parent. | B/ONK,HEM | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu L-asparaginázou ordinuje onkolog nebo hematolog. Revizní lékař pojišťovny může na základě žádosti lékaře povolit plnou úhradu ekonomicky náročnějších přípravků obsahujících L-asparaginázu v případě, že se jedná o podání dětem do 18 let věku, nebo že se jedná o opakované podání starším osobám, případně u pacientů s alergickou anamnézou.
| 312.1 | L01XX01 | amsakrin | parent. | 1 | MG | 26,75 | B/ONK,HEM | | 93503 | AMSIDYL | inj 6x85mg/1.7ml+so | GOD | D | | | | | 312.2 | L01XX02 | asparagináza | parent. | 1 | MG | 2848,40 | B/P | | 92117 | KIDROLASE | inj sic 10x10ku | RBE | F | | | | | 312.3 | L01XX11 | estramustin | parent. | 1 | MG | 1,15 | B/ONK,HEM,URN | | 40624 | ESTRACYT 300MG | inj sic 10x300mg+sol | PHA | S | | | | | 312.4 | L01XX13 | dakarbazin | parent. | 10 | MG | 8,10 | B/ONK,HEM | | 88440 | DACARBAZIN LACHEMA 100 | inj sic 10x100mg | LCM | CZ | | | | | 88441 | DACARBAZIN LACHEMA 200 | inj sic 10x200mg | LCM | CZ | | | | | 312.5 | L01XX17 | topotekan | parent. | 1 | MG | 3136,70 | X | | | | | | | | | | | 312.6 | L01XX19 | irinotekan | parent. | 1 | MG | 79,10 | X | | 313 | L02AA | estrogeny | p.o. | L/ONK,HEM,URN,GYN, SEX | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 313.1 | L02AA01 | diethylstilbestrol | p.o. | 10 | MG | 3,40 | L/ONK,HEM,URN GYN,SEX | | | | | | | | | | | 313.2 | L02AA03 | ethinylestradiol | p.o. | 1 | MG | 4,15 | L/ONK,HEM,URN GYN,SEX | | 87548 | TURISTERON | drg 21x1mg | VJP | D | | | | | 313.3 | L02AA04 | fosfestrol | p.o. | 0.1 | GM | 3,40 | L/ONK,HEM,URN GYN,SEX | | 314 | L02AA | estrogeny | parent. | B/ONK,HEM,URN,SEX | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 314.1 | L02AA | polyestradioli phosphas | parent. | 1 | MG | 3,25 | B/ONK,HEM, URN,SEX | | 88381 | ESTRADURIN | inj sic 10x80mg+2ml | KBP | S | | | | | 314.2 | L02AA01 | diethylstilbestrol | parent. | 10 | MG | 6,70 | B/ONK,HEM, URN,SEX | | | | | | | | | | | 314.3 | L02AA04 | fosfestrol | parent. | 0.1 | GM | 4,90 | B/ONK,HEM, URN,SEX | | 315 | L02AB | progestiny | p.o. | L/ONK,HEM,URN,GYN, SEX | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 315.1 | L02AB01 | megestrol | p.o. | 10 | MG | 3,15 | L/ONK,HEM,URN GYN,SEX | | 86059 | MEGACE | tbl 100x160mg | BMS | D | | | | | 86211 | MEGACE | tbl 100x40mg | BMS | D | | | | | 315.2 | L02AB02 | medroxyprogesteron | p.o. | 10 | MG | 2,00 | L/ONK,HEM,URN GYN,SEX | | 88429 | FARLUTAL | tbl 30x500mg | FAR | I | | | | | 91618 | PROVERA | tbl 20x500mg | UPJ | GB | | | | | 90793 | PROVERA 100MG | tbl 100x100mg | UPJ | GB | | | | | 316 | L02AB | progestiny | parent. | L/ONK,GYN,SEX | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 316.1 | L02AB02 | medroxyprogesteron | parent. | 10 | MG | 3,35 | L/ONK,GYN,SEX | | 90993 | DEPO-PROVERA 500 | inj 1x3.3ml/500mg | UPJ | B | | | | | 85678 | FARLUTAL DEPOT | inj 1x2.5ml/500mg | PHA | I | | | | | 316.2 | L02AB03 | gestonoron | parent. | 1 | MG | 1,15 | L/ONK,GYN,SEX | | 317 | L02AE | hormon uvolňující gonadotrofin a jeho deriváty | inhal. | Z | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 317.1 | L02AE01 | buserelin | inhal. | 1 | MG | 242,30 | Z | | 90966 | SUPREFACT NASAL | sol nas 4x10gm/10mg | HOE | D | | | | | 318 | L02AE | hormon uvolňující gonadotrofin a jeho deriváty | parent. | K/P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu ordinuje onkolog, urolog, endokrinolog nebo gynekolog:
- a) léčba karcinomu prsní žlázy u premenopauzálních a perimenopauzálních žen, jen po dobu adjuvantní chemo- nebo radioterapie.
- b) léčba karcinomu prostaty,
- c) léčba myomatózy spojené s poruchou fertility nebo její těžké formy vyžadující předoperační redukci nálezu,
- d) léčba těžkých, jinak konzervativně nereagujících forem endometriózy,
- e) pubertas precox,
- f) indukce ovulace při in vitro fertilizaci pouze na základě předchozího schválení revizním lékařem.
| 318.1 | L02AE01 | buserelin | parent. | 1 | MG | 273,65 | K/P |
|---|---|---|---|---|---|---|---|
| 318.2 | L02AE01 | buserelin (depotní lékové formy) | parent. | 1 | MG | 2075,80 | K/P |
| 75018 | SUPREFACT DEPOT | imp 2x3.3mg+aplik. | HOE | D | |||
| 318.3 | L02AE02 | leuprorelin | parent. | 1 | MG | 273,65 | K/P |
| 318.4 | L02AE02 | leuprorelin (depotní lékové formy) | parent. | 1 | MG | 1852,35 | K/P |
| 76553 | LUCRIN DEPOT 3.75MG | inj sic 1+solv+str. | ABB | E | |||
| 318.5 | L02AE03 | goserelin (depotní lékové formy) | parent. | 1 | MG | 1944,45 | K/P |
| 12320 | ZOLADEX 10.8MG DEPOT | inj 1x10.8mg | ZNC | GB | |||
| 65386 | ZOLADEX DEPOT | inj 1x3.6mg | ZNC | GB | |||
| 318.6 | L02AE04 | triptorelin | parent. | 1 | MG | 273,65 | K/P |
| 318.7 | L02AE04 | triptorelin (depotní lékové formy) | parent. | 1 | MG | 1768,45 | K/P |
| 96107 | DECAPEPTYL DEPOT | inj sic 3.75mg+2ml | FEI | D | |||
| 319 | L02BA | antiestrogeny | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 319.1 | L02BA01 | tamoxifen (do 20 mg v 1 tabletě včetně) | p.o. | 10 | MG | 3,45 | |
| 67039 | TAMIFEN 10 | tbl 30x10mg | MOE | CY | |||
| 44056 | TAMOXIFEN EBEWE 10 | tbl 30x10mg | EBW | A | |||
| 44057 | TAMOXIFEN EBEWE 20 | tbl 30x20mg | EBW | A | |||
| 88392 | TAMOXIFEN LACHEMA 10 | tbl 100x10mg | LCM | CZ | |||
| 71959 | ZITAZONIUM 10MG | tbl 10x10mg | EGI | H | |||
| 71958 | ZITAZONIUM 10MG | tbl 30x10mg | EGI | H | |||
| 44144 | ZITAZONIUM 20MG | tbl 30x20mg | EGI | H | |||
| 31243 | ZITAZONIUM 20MG | tbl 60x20mg | EGI | H | |||
| 31037 | ZITAZONIUM | tbl 60x10mg | EGI | H | |||
| 319.2 | L02BA01 | tamoxifen (nad 20 mg v 1 tabletě) | p.o. | 10 | MG | 2,50 | |
| 44058 | TAMOXIFEN EBEWE 30 | tbl 30x30mg | EBW | A | |||
| 44059 | TAMOXIFEN EBEWE 40 | tbl 30x40mg | EBW | A | |||
| 31384 | ZITAZONIUM 40MG | tbl 30x40mg | EGI | H | |||
| 44146 | ZITAZONIUM 30MG | tbl 30x30mg | EGI | H | |||
| 320 | L02BB | antiandrogeny | p.o. | L/ONK,URN,SEX | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 320.1 | L02BB01 | flutamid | p.o. | 10 | MG | 1,35 | L/ONK,URN,SEX |
| 55953 | FLUTACAN 250MG | tbl 100x250mg | LOY | SF | |||
| 83392 | FLUCINOM | tbl 100x250mg | SCH | B | |||
| 80088 | FLUCINOM (EULEXIN 85) | tbl 100x250mg | SCH | USA | |||
| 320.2 | L02BB02 | nilutamid | p.o. | 1 | MG | 0,70 | L/ONK,URN,SEX |
| 94820 | ANANDRON | tbl 90x50mg | ROU | F | |||
| 320.3 | L02BB03 | bicalutamid | p.o. | 50 | MG | 101,25 | L/ONK,URN,SEX |
| 321 | L02BG | inhibitory tvorby steroidních hormonů | p.o. | L/ONK,END | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 321.1 | L02BG01 | aminogluthetimid | p.o. | 10 | MG | 0,70 | L/ONK,END |
| 07510 | ORIMETEN | tbl 100x250mg | CGC | CH | |||
| 321.2 | L02BG03 | anastrozol | p.o. | 1 | MG | 200,25 | X |
| 321.3 | L02BG04 | letrozol | p.o. | 2,5 | MG | 200,25 | X |
| 322 | L02BG | inhibitory tvorby steroidních hormonů | parent. | X | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 322.1 | L02BG02 | formestan | parent. | 250 | MG | 4068,20 | X |
| 92361 | LENTARON DEPOT 250MG I.M. | inj sic 1x250mg+2ml | CGC | CH | |||
| 323 | L03AA | cytokiny | parent. | X | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 323.1 | L03AA01 | interleukin 2 | parent. | 1 | MG | 8006,85 | X |
| 323.2 | L03AA02 | filgrastim | parent. | 1 | MG | 13931,75 | X |
| 98297 | NEUPOGEN | inj 5x1.6ml | HLR | CH | |||
| 69026 | NEUPOGEN | inj 5x1ml | HLR | CH | |||
| 323.3 | L03AA03 | molgramostim | parent. | 1 | MG | 14357,35 | X |
| 96865 | LEUCOMAX | inj sic 0.15mg+1ml | SAN | CH | |||
| 72549 | LEUCOMAX | inj sic 0.3mg+1ml | SAN | CH | |||
| 96866 | LEUCOMAX | inj sic 0.4mg+1ml | SAN | CH | |||
| 323.4 | L03AA10 | lenograstim | parent. | 1 | MG | 18193,20 | X |
| 12953 | GRANOCYTE 34 | lyo 5x33.6mu+solv. | RRO | F | |||
| 323.5 | L03AA04 | interferon alfa | parent. | 1 | MU | 245,00 | X |
| 83942 | HEBERON ALFA R | inj sic 25x3mu | HBC | C | |||
| 89225 | ROFERON A | inj 1x3ml/18mu | HLR | CH | |||
| 25776 | WELFERON | inj 1x1ml/5mu | BWE | GB | |||
| 93101 | WELLFERON | inj 1x1ml/10mu | BWE | GB | |||
| 80514 | HEBERON ALFA R | inj sic 1x3mu | HBC | C | |||
| 91641 | INTRON A | inj 1x10mu | SCH | IRL | |||
| 91639 | INTRON A | inj 1x3mu | SCH | IRL | |||
| 91640 | INTRON A | inj 1x5mu | SCH | IRL | |||
| 323.6 | L03AA08 | interferon gamma | parent. | 1 | MU | 1566,45 | X |
| 323.7 | L03AA11 | interferon beta 1b | parent. | 1 | MU | 330,15 | X |
| 87312 | BETAFERON | inj sic 15+15x2ml | SAG | D | |||
| 323.8 | L03AA11 | interferon beta 1a | parent. | 1 | MU | 440,20 | X |
| 324 | L03AX | ostatní imunostimulační léčiva | lok., p.o. | L/ALG | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 324.1 | L03AX | směs bakteriálních lyzátů | lok. | 1 | BA | 75% | L/ALG |
| 324.2 | L03AX | směs bakteriálních lyzátů | p.o. | 1 | BA | 75% | |
| 324.3 | L03AX | vaccin. staphyl. phagolys. | lok. | 1 | ML | 37,35 | L/ALG |
| 94631 | STAVA-NASAL | gtt 10x5ml | BIU | CZ | |||
| 325 | L03AX | ostatní imunostimulační léčiva | parent. | O | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 325.1 | L03A | dialyzát lidských leukocytů | parent. | 1 | DF | 1011,05 | O/ALG,IMU |
| 56930 | IMMODIN SEVAC | inj sic 1x2ml+solv. | SEV | CZ | |||
| 97146 | IMMODIN SEVAC | inj sic 5x2ml+solv. | SEV | CZ | |||
| 325.2 | L03A | thymostimulin (do 10 mg včetně v jedné ampuli) | parent. | 1 | MG | 66,35 | Z |
| 69035 | TP-1 SERONO | inj sic 1x10mg+sol | SRO | CH | |||
| 325.3 | L03AX | bac. propionibacterii acnes | parent. | 1 | MG | 74,50 | O/ONK |
| 325.4 | L03AX | laktobacillus acidophilus | parent. | 3 | DF | 639,80 | O/GYN |
| 325.5 | L03AX | vaccin. staphyl. phagolys. | parent. | 1 | DF | 74,65 | O |
| 325.6 | L03AX03 | BCG vakcína | parent. | 1 | MG | 44,35 | O/ONK,URN |
| 325.7 | L03AX | dialyzát vepřových leukocytů | p.o. | 75% | O/ALG,IMU | ||
| 325.8 | L03A | thymostimulin (nad 10 mg včetně v jedné ampuli) | parent. | 1 | MG | 46,35 | Z |
| 69041 | TP-1 SERONO | inj sic 1x50mg+sol | SRO | CH | |||
| 326 | L04AA | selektivní imunosupresivní léčiva | p.o. | P | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu cyklosporinem ordinuje lékař pracující v transplantačních centrech, onkolog, hematolog, dermatolog, urolog a revmatolog:
- a) prevence reakce štěpu proti hostiteli po transplatnacích,
- b) léčba myelodysplaastického sysndromu nereagující na standardní léčbu,
- c) léčba aplastické anemie nereagující na standardní léčbu,
- d) léčba autoimunní hemolytické anemie a autoimunní trombocytopenické purpury nereagující na standardní léčbu,
- e) léčba nefrotického syndromu nereagující na standardní léčbu,
- f) těžké formy revmatoidní artritidy dospělých a dětí se středně těžkým a těžkým průběhem kloubního postižení nebo se současným postižením jiných orgánů (zvláště plic),
- g) těžké generalizované formy psoriázy (psoriasis vulgaris, arthropatica, pustulosa) nereagující na standardní léčbu,
- h) systémový lupus erythematodes nereagující na standardní léčbu,
- i) těžké formy polymyositidy/dermatomyositidy nereagující na standardní léčbu.
Léčba se zahajuje obvykle v rámci hospitalizace pacienta s odpovídajícím odstupem od jiné terapie (např. PUVA, retinoidy, cytostatika), léčbu provádí pouze pracoviště s dostupností příslušných laboratorních vyšetření (včetně stanovení hladiny cyklosporinu).
Léčbu mophetil mycophenolatem ordinuje lékař pracující v transplantačních centrech v indikaci profylaxe rejekce štěpu proti hostiteli pouze u pacientů, u kterých byla provedena alogenní transplantace ledvin. Podává se v kombinaci s cyklosporinem a kortikosteroidy.
| 326.1 | L04AA01 | cyklosporin | p.o. | 1 | MG | 1,40 | P | | 94052 | CONSUPREN | sol 1x50ml 100mg/ml | GNO | CZ | | | | | 92572 | CONSUPREN 25MG | cps 50x25mg | GNO | CZ | | | | | 92573 | CONSUPREN 50MG | cps 50x50mg | GNO | CZ | | | | | 92574 | CONSUPREN 100MG | cps 50x100mg | GNO | CZ | | | | | 84047 | SANDIMMUN NEORAL 100MG/ML | sol 1x50ml 100mg/ml | SAN | CH | | | | | 84044 | SANDIMMUN NEORAL 25MG | cps 50x25mg | SAN | CH | | | | | 84045 | SANDIMMUN NEORAL 50MG | cps 50x50mg | SAN | CH | | | | | 84046 | SANDIMMUN NEORAL 100MG | cps 50x100mg | SAN | CH | | | | | 326.2 | L04AA06 | mophetil mycophenolát | p.o. | 10 | MG | 2,60 | P | | 55681 | CELLCEPT | cps 100x250mg | HLR | CH | | | | | 327 | L04AA | selektivní imunosupresivní léčiva | parent. | U/J10 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 327.1 | L04AA | antilymfocytární IG | parent. | 10 | MG | 106,25 | U/J10 | | | | | | | | | | | 327.2 | L04AA | antithymocytární IG | parent. | 1 | MG | 124,25 | U/J10 | | | | | | | | | | | 327.3 | L04AA01 | cyklosporin | parent. | 1 | MG | 2,70 | U/J10 | | 95041 | SANDIMMUN KONZENTRAT | inf 10x1ml 50mg/1ml | SAN | CH | | | | | 88514 | SANDIMMUN KONZENTRAT | inf 10x5ml 50mg/1ml | SAN | CH | | | | | 327.4 | L04AA02 | muromonab-CD3 | parent. | 1 | MG | 2276,90 | U/J10 | | 96997 | CEDETRIN-T(MONOK.PROTIL.A1-CD3) | inj 10x3.2ml | EXB | CZ | | | | | 93351 | ORTHOCLONE OKT 3 | inj 5x5ml 1mg/ml | CIL | CH | | | | | 328 | L04AX | ostatní imunosupresiva | p.o. | L/J10,REV,HEM | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 328.1 | L04AX01 | azathioprin (do 25 mg v jedné tabletě včetně) | p.o. | 10 | MG | 1,60 | L/J10,REV,HEM, NEU,OPH,DER | | 31396 | IMURAN | tbl obd 100x25mg | BWE | GB | | | | | 328.2 | L04AX01 | azathioprin (nad 25 mg v jedné tabletě) | p.o. | 10 | MG | 1,15 | L/J10,REV,HEM, NEU,OPH,DER | | 02418 | IMURAN | tbl obd 100x50mg | BWE | GB | | | | | 329 | L04AX | ostatní imunosupresiva | parent. | U/J10 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 329.1 | L04AX01 | azathioprin | parent. | 1 | MG | 10,05 | U/J10 | | 02016 | IMURAN | inj sic 1x50mg+2ml | BWE | GB | | | | | 330 | M01AA | protizánětlivá léčiva ze skupiny butylpyrazolidinů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 330.1 | M01AA | butylpyrazolidiny | p.o. | 3 | DF | 3,40 | | | 00179 | KETAZON | drg 20x250mg | LEX | CZ | | | | | 330.2 | M01AA05 | klofezon | p.o. | 0.6 | GM | 3,40 | | | 331 | M01AA | protizánětlivá léčiva ze skupiny butylpyrazolidinů | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 331.1 | M01AA | butylpyrazolidiny | parent. | 1 | DF | 7,05 | | | 00490 | KETAZON | inj 5x5ml/1gm | LEX | CZ | | | | | 332 | M01AB | protizánětlivá léčiva ze skupiny derivátů kyseliny octové | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 332.1 | M01AB | deriváty kyseliny octové | p.o. | 70 | MG | 1,80 | | | 88917 | REPANIDAL | cps 30x35mg | LEX | CZ | | | | | 332.2 | M01AB01 | indometacin | p.o. | 0.1 | GM | 3,25 | | | 77078 | APO-INDOMETHACIN 50MG | cps 100x50mg | APT | CND | | | | | 97713 | APO-INDOMETHACIN 25MG | cps 100x25mg | APT | CND | | | | | 67403 | INDOBENE 50MG | cps 20x50mg | MCK | D | | | | | 67404 | INDOBENE 50MG | cps 50x50mg | MCK | D | | | | | 02630 | INDREN | cps 30x25mg | LEX | CZ | | | | | 332.3 | M01AB02 | sulindac | p.o. | 0.4 | GM | 5,20 | | | | | | | | | | | | 332.4 | M01AB03 | tolmetin | p.o. | 0.7 | GM | 5,20 | | | | | | | | | | | | 332.5 | M01AB05 | diklofenak | p.o. | 0.1 | GM | 5,20 | | | 96740 | APO-DICLO 25MG | tbl ent 100x25mg | APT | CND | | | | | 96742 | APO-DICLO 50MG | tbl ent 100x50mg | APT | CND | | | | | 55586 | DICLOFENAC 25 LÉČIVA | tbl obd 30x25mg | LEX | CZ | | | | | 75605 | DICLOFENAC AL 25 | tbl obd 100x25mg | APA | D | | | | | 75603 | DICLOFENAC AL 25 | tbl obd 20x25mg | APA | D | | | | | 75604 | DICLOFENAC AL 25 | tbl obd 50x25mg | APA | D | | | | | 89026 | DICLOFENAC AL 50 | tbl obd 100x50mg | APA | D | | | | | 89024 | DICLOFENAC AL 50 | tbl obd 20x50mg | APA | D | | | | | 89025 | DICLOFENAC AL 50 | tbl obd 50x50mg | APA | D | | | | | 75633 | DICLOFENAC AL RETARD | tbl obd 100x100mg | APA | D | | | | | 75631 | DICLOFENAC AL RETARD | tbl obd 20x100mg | APA | D | | | | | 75632 | DICLOFENAC AL RETARD | tbl obd 50x100mg | APA | D | | | | | 67541 | ALMIRAL 50 | tbl ent 20x50mg | MOE | CY | | | | | 67551 | ALMIRAL SR 100 | tbl ret 10x100mg | MOE | CY | | | | | 99893 | DICLOFENAC PHARMAVIT 100MG RET. | tbl obd 30x100mg | PVI | H | | | | | 99892 | DICLOFENAC PHARMAVIT 50MG | tbl fc 30x50mg | PVI | H | | | | | 66954 | MONOFLAM 25MG | tbl obd 100x25mg | LIC | D | | | | | 66950 | MONOFLAM 25MG | tbl obd 20x25mg | LIC | D | | | | | 66952 | MONOFLAM 25MG | tbl obd 50x25mg | LIC | D | | | | | 66955 | MONOFLAM 50MG | tbl obd 100x50mg | LIC | D | | | | | 66951 | MONOFLAM 50MG | tbl obd 20x50mg | LIC | D | | | | | 66953 | MONOFLAM 50MG | tbl obd 50x50mg | LIC | D | | | | | 67505 | MONOFLAM RETARD | cps ret 20x100mg | LIC | D | | | | | 67506 | MONOFLAM RETARD | cps ret 50x100mg | LIC | D | | | | | 67507 | MONOFLAM RETARD | cps ret 100x100mg | LIC | D | | | | | 75461 | REWODINA RETARD | tbl obd 50x100mg | VAD | D | | | | | 75462 | REWODINA RETARD | tbl obd 100x100mg | VAD | D | | | | | 98144 | VERAL 25MG | tbl 30x25mg | SLO | SK | | | | | 83518 | VERAL 50MG | tbl ent 20x50mg | SLO | SK | | | | | 83519 | VERAL 50MG | tbl ent 50x50mg | SLO | SK | | | | | 332.6 | M01AB05 | diklofenak (lékové formy s rychlým nástupem účinku) | p.o. | 0.1 | GM | 5,75 | | | 89136 | DICLOFENAC DUO PHARMAVIT 75MG | cps ret 30x75mg | PVI | H | | | | | 332.7 | M01AB06 | alclofenak | p.o. | 1.25 | GM | 5,20 | | | | | | | | | | | | 332.8 | M01AB09 | lonazolak | p.o. | 0.6 | GM | 5,20 | | | | | | | | | | | | 332.9 | M01AB16 | aceklofenak | p.o. | 0.2 | GM | 5,20 | | | | | | | | | | | | 332.10 | M01AB55 | diklofenak/misoprostol (na obsah diklofenaku) | p.o. | 0.1 | GM | 30,00 | Z | | 333 | M01AB | protizánětlivá léčiva ze skupiny derivátů kyseliny octové | p.rect. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 333.1 | M01AB01 | indometacin | p.rect. | 0.1 | GM | 3,45 | | | 02789 | INDOMETACINUM | sup 5x100mg | CHN | H | | | | | 333.2 | M01AB03 | tolmetin | p.rect. | 0.7 | GM | 10,80 | | | | | | | | | | | | 333.3 | M01AB05 | diklofenak | p.rect. | 0.1 | GM | 10,80 | | | 91969 | DICLOBERL 50 | sup 10x50mg | BCE | D | | | | | 99894 | DICLOFENAC PHARMAVIT 100MG | sup 6x100mg | PVI | H | | | | | 66957 | MONOFLAM 100MG | sup 10x100mg | LIC | D | | | | | 66956 | MONOFLAM 50MG | sup 10x50mg | LIC | D | | | | | 76913 | REWODINA 100 | sup 10x100mg | VAD | D | | | | | 76912 | REWODINA 50 | sup 10x50mg | VAD | D | | | | | 87206 | VERAL 100MG | sup 10x100 | SLO | SK | | | | | 333.4 | M01AB09 | lonazolak | p.rect. | 0.6 | GM | 10,80 | | | 334 | M01AB | protizánětlivá léčiva ze skupiny derivátů kyseliny octové | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 334.1 | M01AB01 | indometacin | parent. | 0.1 | GM | 13,20 | | | | | | | | | | | | 334.2 | M01AB05 | diklofenak | parent. | 0.1 | GM | 13,20 | | | 94632 | VERAL | inj 5x3ml | LEX | CZ | | | | | 335 | M01AC | protizánětlivá léčiva ze skupiny oxikamů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 335.1 | M01AC01 | piroxikam | p.o. | 20 | MG | 2,55 | | | 97711 | APO-PIROXICAM 10 | cps 100x10mg | APT | CND | | | | | 97710 | APO-PIROXICAM 20 | cps 100x20mg | APT | CND | | | | | 91721 | ARTHREMIN 10 | cps 30x10mg | LEX | CZ | | | | | 71947 | ARTHREMIN 20 | cps 30x20mg | LEX | CZ | | | | | 68581 | PIROX 10 | tbl 50x10mg | CTA | D | | | | | 335.2 | M01AC02 | tenoxikam | p.o. | 20 | MG | 2,55 | | | | | | | | | | | | 335.3 | M01AC06 | meloxikam | p.o. | 15 | MG | 14,65 | L/ORT,REV | | | | | | | | | | | 335.4 | M01AC01 | piroxikam (lékové formy s rychlým nástupem účinku) | p.o. | 20 | MG | 5,75 | | | 336 | M01AC | protizánětlivá léčiva ze skupiny oxikamů | p.rect. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 336.1 | M01AC01 | piroxikam | p.rect. | 20 | MG | 11,40 | | | 67172 | PIROX 20 | sup 10x20mg | CTA | D | | | | | 336.2 | M01AC02 | tenoxikam | p.rect. | 20 | MG | 11,50 | | | | | | | | | | | | 336.3 | M01AC06 | meloxikam | p.rect. | 15 | MG | 11,50 | | | 337 | M01AC | protizánětlivá léčiva ze skupiny oxikamů | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 337.1 | M01AC01 | piroxikam | parent. | 20 | MG | 12,30 | | | 89853 | PIROX 20 VON CT | inj 5x1ml/20mg | CTA | D | | | | | 337.2 | M01AC02 | tenoxikam | parent. | 20 | MG | 12,10 | | | 338 | M01AE | protizánětlivá léčiva ze skupiny derivátů kyseliny propionové | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 338.1 | M01AE01 | ibuprofen | p.o. | 1.2 | GM | 3,45 | | | 97989 | APO-IBUPROFEN 400MG | tbl 100x400mg | APT | CND | | | | | 83721 | IBUPROFEN DH 400MG DIAG HUMAN | tbl obd 30x400mg | GNS | GB | | | | | 98321 | IBUPROFEN DH 400MG DIAG HUMAN | tbl obd 250x400mg | GNS | GB | | | | | 98324 | IBUPROFEN DH 600MG DIAG HUMAN | tbl obd 250x600mg | GNS | GB | | | | | 66990 | DOLGIT 800 | tbl obd 20x800mg | DLR | D | | | | | 338.2 | M01AE01 | ibuprofen (lékové formy sirupu) | p.o. | 1.2 | GM | 20,00 | | | | | | | | | | | | 338.3 | M01AE02 | naproxen (pevné lékové formy) | p.o. | 0.5 | GM | 5,20 | | | 97983 | APO-NAPROXEN 250MG | tbl 100x250mg | APT | CND | | | | | 338.4 | M01AE02 | naproxen (tekuté lékové formy) | p.o. | 0.5 | GM | 13,45 | | | | | | | | | | | | 338.5 | M01AE03 | ketoprofen | p.o. | 0.15 | GM | 5,20 | | | 76655 | KETONAL | cps 25x50mg | LEK | SLO | | | | | 76653 | KETONAL FORTE | tbl obd 20x100mg | LEK | SLO | | | | | 76654 | KETONAL RETARD | tbl ret 20x150mg | LEK | SLO | | | | | 338.6 | M01AE07 | suprofen | p.o. | 0.4 | GM | 5,20 | | | | | | | | | | | | 338.7 | M01AE08 | pirprofen | p.o. | 0.8 | GM | 5,20 | | | | | | | | | | | | 338.8 | M01AE09 | flurbiprofen | p.o. | 0.2 | GM | 5,20 | | | | | | | | | | | | 338.9 | M01AE10 | indoprofen | p.o. | 0.6 | GM | 5,20 | | | | | | | | | | | | 338.10 | M01AE11 | kyselina tiaprofenová | p.o. | 0.6 | GM | 8,80 | | | 96484 | SURGAM | tbl 20x300mg | LEX | CZ | | | | | 338.11 | M01AG02 | kyselina tolfenámová | p.o. | 0.3 | GM | 5,20 | | | 339 | M01AE | protizánětlivá léčiva ze skupiny derivátů kyseliny propionové | p.rect. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 339.1 | M01AE01 | ibuprofen | p.rect. | 1.2 | GM | 9,60 | | | | | | | | | | | | 339.2 | M01AE02 | naproxen | p.rect. | 0.5 | GM | 11,40 | | | 67107 | NAPROXEN 500 VON CT | sup 10x500mg | CTA | D | | | | | 339.3 | M01AE03 | ketoprofen | p.rect. | 0.15 | GM | 9,60 | | | 76652 | KETONAL | sup 12x100mg | LEK | SLO | | | | | 06171 | PROFENID 100MG | sup 12 | SPC | F | | | | | 339.4 | M01AE11 | kyselina tiaprofenová | p.rect. | 0.6 | GM | 11,40 | | | 340 | M01A | protizánětlivá léčiva ze skupiny derivátů kyseliny propionové a fenamátů | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 340.1 | M01AE01 | ibuprofen | parent. | 1.2 | GM | 14,70 | | | | | | | | | | | | 340.2 | M01AE02 | naproxen | parent. | 0.5 | GM | 14,70 | | | | | | | | | | | | 340.3 | M01AE03 | ketoprofen | parent. | 0.15 | GM | 14,70 | | | 76657 | KETONAL I.M. | inj 10x2ml/100mg | LEK | SLO | | | | | 340.4 | M01AG | etofenamat | parent. | 1 | GM | 14,70 | | | 341 | M01AX | ostatní protizánětlivá léčiva | p.o. | L/REV | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 341.1 | M01AX01 | nabumeton | p.o. | 1 | GM | 29,25 | L/REV,ORT | | 83731 | RELIFEX | tbl obd 20x500mg | LEX | CZ | | | | | 341.2 | M01AX04 | azapropazon | p.o. | 0.75 | GM | 5,20 | | | | | | | | | | | | 341.3 | M01AX05 | glukosamin sulfat | p.o. | 1.5 | GM | 11,70 | L/REV | | | | | | | | | | | 341.4 | M01AX13 | proquazon | p.o. | 0.9 | GM | 5,20 | | | | | | | | | | | | 341.5 | M01AX17 | nimesulid (pevné lékové formy) | p.o. | 0.2 | GM | 14,65 | L/REV,ORT | | | | | | | | | | | 341.6 | M01AX17 | nimesulid (tekuté lékové formy) | p.o. | 0.2 | GM | 20,00 | L/REV,PDD | | | | | | | | | | | 341.7 | M01AX17 | nimesulid | p.rect. | 0.2 | GM | 14,65 | L/REV,ORT | | 342 | M01CB | léčiva obsahující zlato | parent. | L/REV | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 342.1 | M01CB01 | aurothiomalát sodný | parent. | 2.4 | MG | 6,75 | L/REV | | 02780 | TAUREDON | inj 10x0.5ml/50mg | BGL | D | | | | | 02781 | TAUREDON | inj 10x0.5ml/20mg | BGL | D | | | | | 343 | M01C | penicilamin a ostatní chorobu modifikující léčiva včetně skupiny M09 | p.o., parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu kyselinou hyaluronovou ordinuje ortoped nebo revmatolog:
součást léčby primární osteoarthrózy kolenních kloubů, rentgenologicky II. a III. stádium dle Kellgrena, při pravidelných bolestech větší intenzity, nebo u pacientů, u kterých je léčba nesteroidními antirevmatiky kontraindikována.
| 343.1 | M01CC01 | penicilamin (do 150 mg v jedné tabletě včetně) | p.o. | 0.5 | GM | 33,60 | | | 66755 | METALCAPTASE | tbl obd 50x150mg | KNO | D | | | | | 343.2 | M01CC01 | penicilamin (nad 150 mg v jedné tabletě) | p.o. | 0.5 | GM | 23,40 | | | 92732 | TROLOVOL | tbl obd 50x300mg | ASD | D | | | | | 09738 | TROLOVOL | tbl obd 100x300mg | ASD | D | | | | | 343.3 | M09AX01 | kyselina hyaluronová | parent. | 3.6 | MG | 200,00 | P | | | | | | | | | | | 343.4 | M09AX02 | chondroitin sulfat | p.o. | 1.6 | GM | 15,00 | L/REV,ORT | | 344 | M02AA | nesteroidní protizánětlivá léčiva k zevnímu podání | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 344.1 | M02AA | protizánětlivé přípr., nesteroidní, k zevnímu použití | lok. | 1 | GM | 1,00 | | | | | | | | | | | | 344.2 | M02AA | ketofenylbutazon | lok. | 1 | GM | 1,00 | | | 00865 | KETAZON 10% | ung 1x20gm | LEX | CZ | | | | | 344.3 | M02AA05 | benzydamin | lok. | 1 | GM | 1,00 | | | | | | | | | | | | 344.4 | M02AA06 | etofenamát | lok. | 1 | GM | 1,00 | | | | | | | | | | | | 344.5 | M02AA07 | piroxikam | lok. | 1 | GM | 1,00 | | | 84448 | REUMADOR | gel 1x58gm | SLO | SK | | | | | 344.6 | M02AA10 | ketoprofen | lok. | 1 | GM | 1,00 | | | | | | | | | | | | 344.7 | M02AA13 | ibuprofen | lok. | 1 | GM | 1,00 | | | 75289 | DOLGIT | crm 1x100gm/5gm | DLR | D | | | | | 344.8 | M02AA15 | diklofenak | lok. | 1 | GM | 1,00 | | | 67550 | ALMIRAL GEL | gel 1x250gm | MOE | CY | | | | | 67549 | ALMIRAL GEL | gel 1x25gm | MOE | CY | | | | | 55478 | DICLOFENAC LÉČIVA | gel 1x35gm 1% | LEX | CZ | | | | | 76911 | FLECTOR EP GEL | gel 1x100gm | IBS | CH | | | | | 76910 | FLECTOR EP GEL | gel 1x60gm | IBS | CH | | | | | 76777 | VERAL | gel 1x55gm | SLO | SK | | | | | 344.9 | M02AA15 | diklofenak (transdermální lékové formy) | transd. | 2 | DF | 5,20 | | | | | | | | | | | | 344.10 | M02AA17 | kyselina niflumová | lok. | 1 | GM | 1,00 | | | 98246 | NIFLUGEL 2.5% | gel 1x60gm 2.5% | UPS | F | | | | | 98244 | NIFLURIL | crm 1x60gm | UPS | F | | | | | 344.11 | M02AA21 | tolectin | lok. | 1 | GM | 1,00 | | | | | | | | | | | | 344.12 | M02AA23 | indomethacin | lok. | 1 | GM | 1,00 | | | 67409 | INDOBENE | gel 1x100gm | MCK | D | | | | | 88595 | INDOMETACINOVY GEL 1% GLO | gel 1x50gm | GAO | CZ | | | | | 66959 | VONUM CUTAN | ung 1x75gm | LIC | D | | | | | 345 | M02AC | deriváty kyseliny salicylové k lokálnímu podání | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 345.1 | M02AC | přípravky s deriváty kyseliny salicylové | lok. | 1 | GM | 1,00 | | | 03574 | RHEUMOSIN | ung 1x30gm | LEX | CZ | | | | | 346 | M02AX | jiná léčiva k léčbě kloubů a svalů k zevnímu podání | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 346.1 | M02AX | jiné přípr. k léč. kloubů a svalů k zevnímu použ. | lok. | 1 | GM | 1,00 | | | 83872 | UNGUENTUM CAMPHORATUM 10% MVM | ung 1x1kg | MVM | CZ | | | | | 83873 | UNGUENTUM CAMPHORATUM 20% MVM | ung 1x1kg | MVM | CZ | | | | | 91114 | VIPROSAL B | ung 1x50gm | TAL | EST | | | | | 91764 | YELLON | gel 1x50gm | SLO | SK | | | | | 346.2 | M02AX10 | různé | lok. | 1 | GM | 0,40 | | | 00830 | APHLOX | pst 1x200gm | LEX | CZ | | | | | 00803 | PAIN EXPELLER | liq 1x50ml | GNO | CZ | | | | | 347 | M03AA | svalová relaxancia ze skupiny kurarových alkaloidů | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 347.1 | M03AA01 | alkuronium | parent. | 20 | MG | 72,05 | H | | 02519 | ALLOFERIN | inj 50x2ml 10mg | HLR | CH | | | | | 347.2 | M03AA02 | tubokurarin | parent. | 30 | MG | 57,10 | H | | 348 | M03AB | svalová relaxancia ze skupiny derivativátů cholinu | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 348.1 | M03AB | decamethonium | parent. | 10 | MG | 24,30 | H | | | | | | | | | | | 348.2 | M03AB01 | suxamethonium (do 100 mg v jedné ampuli včetně) | parent. | 100 | MG | 59,00 | H | | 97386 | SUCCINYLCHOLINJODID VUAB | inj 1x100mg | VUA | CZ | | | | | 348.3 | M03AB01 | suxamethonium (nad 100 mg v jedné ampuli) | parent. | 100 | MG | 33,75 | H | | 97387 | SUCCINYLCHOLINJODID VUAB | inj 1x250mg | VUA | CZ | | | | | 349 | M03AC | svalová relaxancia ze skupiny kvarterních amoniových derivátů | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 349.1 | M03AC01 | pankuronium | parent. | 10 | MG | 116,20 | H | | | | | | | | | | | 349.2 | M03AC02 | gallamin | parent. | 100 | MG | 44,10 | H | | | | | | | | | | | 349.3 | M03AC03 | vekuronium | parent. | 10 | MG | 116,20 | H | | | | | | | | | | | 349.4 | M03AC04 | atrakurium | parent. | 50 | MG | 118,50 | H | | 97376 | TRACRIUM | inj 2x25ml/250mg | BWE | GB | | | | | 86760 | TRACRIUM | inj 5x2.5ml/25mg | BWE | GB | | | | | 86761 | TRACRIUM | inj 5x5ml/50mg | BWE | GB | | | | | 349.5 | M03AC06 | pipekuronium | parent. | 10 | MG | 105,85 | H | | 349.6 | M03AC10 | mivacuronium | parent. | 10 | MG | 132,55 | H | | 350 | M03AX | ostatní svalová relaxancia | parent. | X | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 350.1 | M03AX01 | botulotoxin (do 100 U v jedné ampuli včetně) | parent. | 100 | U | 8950,00 | X | | | | | | | | | | | 350.2 | M03AX01 | botulotoxin (nad 100 U v jedné ampuli) | parent. | 100 | U | 2612,00 | X | | 97456 | DYSPORT | inj sic 2x500ut | SPY | GB | | | | | 351 | M03BX | jiná centrálně působící svalová relaxancia | p.o. | L/NEU,ORT,REV | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 351.1 | M03BX | tetrazepam | p.o. | 0.1 | GM | 18,00 | L/NEU,ORT,REV | | 56233 | MYOLASTAN | tbl obd 10x50mg | SWI | F | | | | | 351.2 | M03BX01 | baklofen (do 10 mg v jedné tabletě včetně) | p.o. | 50 | MG | 10,20 | | | | | | | | | | | | 351.3 | M03BX01 | baklofen (nad 10 mg v jedné tabletě) | p.o. | 50 | MG | 6,45 | | | | | | | | | | | | 351.4 | M03BX02 | tizanidin (do 2 mg v jedné tabletě včetně) | p.o. | 12 | MG | 27,60 | L/NEU,ORT,REV | | 62523 | SIRDALUD | tbl 20x2mg | SAN | CH | | | | | 351.5 | M03BX02 | tizanidin (nad 2 mg v jedné tabletě) | p.o. | 12 | MG | 20,40 | L/NEU,ORT,REV | | 91284 | SIRDALUD | tbl 30x4mg | SAN | CH | | | | | 351.6 | M03BX04 | tolperison | p.o. | 200 | MG | 2,55 | | | | | | | | | | | | 351.7 | M03BX04 | tolperison | parent. | 200 | MG | 8,40 | | | 352 | M03CA | přímo působící svalová relaxancia | parent. | T | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 352.1 | M03CA01 | dantrolen | parent. | 0.1 | GM | 7718,60 | T | | 91583 | DANTROLEN | inj sic 3x12x20mg+so | RHA | D | | | | | 353 | M04AA | antiuratika inhibující tvorbu kyseliny močové | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 353.1 | M04AA01 | allopurinol | p.o. | 0.4 | GM | 3,50 | | | 97981 | APO-ALLOPURINOL 100MG | tbl 100x100mg | APT | CND | | | | | 354 | M04AB | antiuratika zvyšující vylučování kyseliny močové | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 354.1 | M04AB02 | sulfinpyrazon | p.o. | 0.3 | GM | 5,20 | | | | | | | | | | | | 354.2 | M04AB03 | benzbromaron | p.o. | 0.1 | GM | 1,90 | | | 11854 | DESURIC | tbl 60x100mg | SWI | F | | | | | 355 | M04AC | léčiva užívaná při léčbě dnavého záchvatu | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 355.1 | M04AC01 | kolchicin | p.o. | 1 | MG | 6,00 | | | 62380 | COLCHICUM-DISPERT | tbl obd 50x500rg | KCH | D | | | | | 356 | M05BA | bisfosfonáty | p.o. | P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu ordinuje onkolog, hematolog, internista, ortoped, revmatolog nebo endokrinolog:
- a) osteoporotické patologické zlomeniny,
- b) všechny formy osteoporózy (včetně formy sekundární a osteoporózy indukované kortikosteroidy) potvrzené jedno nebo dvouenergetickou rengenovou absorpcimetrií (T-skóre větší než -2,5 SD) nereagující na standardní léčbu (estrogeny, vápník, vitamin D a jeho deriváty, fluor),
- c) Pagetova choroba se sérovou koncentrací alkalické fosfatázy nejméně dvojnásobné než horní hranice normálních hodnot, při bolestech nebo hypercirkulačním syndromu nebo v případě hrozících komplikací,
- d) hyperkalcémie provázejícící zhoubné nádory s kostními metastázami nebo i bez metastáz, mnohočetný myelom.
| 356.1 | M05BA02 | kyselina klodronová | p.o. | 1.6 | GM | 232,35 | P | | 94460 | BONEFOS 400MG | cps 100x400mg | LOY | SF | | | | | 93985 | LODRONAT | cps 60x500mg | BOM | A | | | | | 356.2 | M05BA04 | kyselina alendronová | p.o. | 10 | MG | 54,70 | P | | 357 | M05BA | bisfosfonáty | parent. | O/P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu ordinuje onkolog, hematolog, internista, ortoped, revmatolog nebo endokrinolog:
- a) osteoporotické patologické zlomeniny,
- b) všechny formy osteoporózy (včetně formy sekundární a osteoporózy indukované kortikosteroidy) potvrzené jedno nebo dvouenergeticko rengenovou absorpcimetrií (T-skóre větší než -2,5 SD) nereagující na standardní léčbu (estrogeny, vápník,vitamin D a jeho deriváty, fluor),
- c) Pagetova choroba se sérovou koncentrací alkalické fosfatázy nejméně dvojnásobné než horní hranice normálních hodnot, při bolestech nebo hypercirkulačním syndromu nebo v případě hrozících komplikací,
- d) hyperkalcémie provázejícící zhoubné nádory s kostními metastázami nebo i bez metastáz, mnohočetný myelom.
| 357.1 | M05BA02 | kyselina klodronová | parent. | 1.5 | GM | 2402,60 | O/P | | 94548 | BONEFOS | inj 5x5ml 60mg/ml | STF | SF | | | | | 93972 | LODRONAT | inj 5x10ml | BOM | A | | | | | 357.2 | M05BA03 | kyselina pamidronová | parent. | 60 | MG | 3844,20 | O/P | | | | | | | | | | | 357.3 | M05BA06 | kyselina ibandronová | parent. | 2 | MG | 9600,00 | O/P | | 358 | N01AA | inhalační anestetika ze skupiny etherů | inhal. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 358.1 | N01AA01 | ether pro anestézii (diethylether) | inhal. | 100 | GM | 15,80 | H | | 00736 | AETHER PRO NARCOSI | inh 200gm | SYT | CZ | | | | | 359 | N01AB | inhalační anestetika ze skupiny halogenovaných uhlovodíků | inhal. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 359.1 | N01AB01 | halotan | inhal. | 100 | ML | 311,95 | H | | 75284 | NARCOTAN | liq 1x250ml | LEX | CZ | | | | | 359.2 | N01AB06 | isofluran | inhal. | 100 | ML | 2343,15 | H | | | | | | | | | | | 359.3 | N01AB06 | sevofluoran | inhal. | 100 | ML | 2343,15 | H | | 360 | N01AF | injkeční anestetika ze skupiny barbiturátů | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 360.1 | N01AF01 | metohexital | parent. | 0.5 | GM | 145,90 | H | | | | | | | | | | | 360.2 | N01AF03 | thiopental (do 500 mg v jedné ampuli včetně) | parent. | 0.5 | GM | 56,20 | H | | 97388 | THIOPENTAL VUAB | inj sic 1x500mg | VUA | CZ | | | | | 360.3 | N01AF03 | thiopental (nad 500 mg v jedné ampuli) | parent. | 0.5 | GM | 32,30 | H | | 97389 | THIOPENTAL VUAB | inj sic 1x1gm | VUA | CZ | | | | | 361 | N01AH | opioidní anestetika (fentanyl) | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 361.1 | N01AH01 | fentanyl (nad 2 ml roztoku v ampuli) | parent. | 1 | MG | 130,55 | O | | 01449 | FENTANYL | inj 50x10ml/0.5mg | JAN | B | | | | | 60911 | FENTANYL | inj 5x10ml/0.5mg | JAN | B | | | | | 361.2 | N01AH01 | fentanyl (do 2 ml roztoku v ampuli včetně) | parent. | 1 | MG | 177,60 | O | | 76526 | FENTANYL | inj 5x2ml/0.1mg | JAN | B | | | | | 76527 | FENTANYL | inj 50x2ml/0.1mg | JAN | B | | | | | 362 | N01AH | opioidní anestetika (ostatní) | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 362.1 | N01AH02 | alfentanyl | parent. | 1.5 | MG | 50,10 | H | | 87723 | RAPIFEN | inj 5x10ml | JAN | B | | | | | 87721 | RAPIFEN | inj 5x2ml | JAN | B | | | | | 362.2 | N01AH03 | sufentanyl (do 10 RG v ampuli včetně) | parent. | 0.6 | MG | 1435,80 | H | | 93701 | SUFENTA I.V. | inj 5x2ml/10rg | JAN | B | | | | | 362.3 | N01AH03 | sufentanyl (nad 50 RG v ampuli) | parent. | 0.6 | MG | 767,55 | H | | 93702 | SUFENTA FORTE I.V. | inj 5x5ml/250rg | JAN | B | | | | | 362.4 | N01AH03 | sufentanyl (od 10 do 50 RG v ampuli včetně) | parent. | 0.6 | MG | 1255,40 | H | | 85526 | SUFENTA FORTE I.V. | inj 5x1ml/50rg | JAN | B | | | | | 93703 | SUFENTA I.V. | inj 5x10ml/50rg | JAN | B | | | | | 362.5 | N01AH51 | fentanyl v kombinacích | parent. | 4 | ML | 39,10 | H | | | | | | | | | | | 362.6 | N01AH06 | remifentanyl | parent. | 1 | MG | 270,35 | H | | 363 | N01AX | ostatní celková anestetika | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 363.1 | N01AX03 | ketamin (koncetrace do 1% včetně) | parent. | 100 | ML | 231,80 | O | | 87779 | NARKAMON | inj 10x10ml 1% | LEX | CZ | | | | | 363.2 | N01AX03 | ketamin (koncentrace nad 1%) | parent. | 10 | ML | 113,00 | O | | 87780 | NARKAMON | inj 5x2ml 5% | LEX | CZ | | | | | 363.3 | N01AX04 | propanidid | parent. | 1 | GM | 32,85 | O | | | | | | | | | | | 363.4 | N01AX07 | etomidát | parent. | 50 | MG | 166,45 | O | | 23511 | RADENARCON | inj 10x10ml/20mg | VAD | D | | | | | 363.5 | N01AX10 | propofol | parent. | 10 | ML | 126,70 | O | | 76089 | DIPRIVAN 1% | inj 5x20ml 10mg/ml | ZNC | GB | | | | | 76091 | DIPRIVAN 1% PRO INFUS. | inj 1x50ml 10mg/ml | ZNC | GB | | | | | 75180 | RECOFOL 10MG/ML | inj 5x20ml/200mg | LOY | SF | | | | | 364 | N01BA | lokální anestetika ze skupiny esterů kyseliny aminobenzoové | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 364.1 | N01BA | estery aminobenzoové kyseliny | parent. | 100 | ML | 13,50 | O | | | | | | | | | | | 364.2 | N01BA02 | prokain (do 10 ml v jedné ampuli včetně) | parent. | 1 | ML | 1,30 | O | | 00564 | PROCAIN LECIVA 1% | inj 10x5ml 1% | LEX | CZ | | | | | 00565 | PROCAIN LECIVA 1% | inj 10x10ml 1% | LEX | CZ | | | | | 364.3 | N01BA02 | prokain (nad 10 ml v jedné ampuli) | parent. | 1 | ML | 0,55 | O | | 69669 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x80ml 0.2% | ARD | CZ | | | | | 69670 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x250ml 0.2% | ARD | CZ | | | | | 69671 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x500ml 0.2% | ARD | CZ | | | | | 69672 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1x80ml 0.5% | ARD | CZ | | | | | 69673 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1x250ml 0.5% | ARD | CZ | | | | | 69674 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1x500ml 0.5% | ARD | CZ | | | | | 69676 | INJECTIO PROCAIN.CHLOR.1% ARD | inj 1x250ml 1% | ARD | CZ | | | | | 69677 | INJECTIO PROCAIN.CHLOR.1% ARD | inj 1x500ml 1% | ARD | CZ | | | | | 86437 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 40x80ml 0.2% | ARD | CZ | | | | | 86444 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 20x250ml 0.2% | ARD | CZ | | | | | 86445 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 12x500ml 0.2% | ARD | CZ | | | | | 86447 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 20x250ml 0.5% | ARD | CZ | | | | | 86448 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 12x500ml 0.5% | ARD | CZ | | | | | 86450 | INJECTIO PROCAIN.CHLOR.1% ARD | inj 20x250ml 1% | ARD | CZ | | | | | 86451 | INJECTIO PROCAIN.CHLOR.1% ARD | inj 12x500ml 1% | ARD | CZ | | | | | 89212 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x200ml 0.2% | ARD | CZ | | | | | 89213 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 20x200ml 0.2% | ARD | CZ | | | | | 89214 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1x200ml 0.5% | ARD | CZ | | | | | 89215 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 20x200ml 0.5% | ARD | CZ | | | | | 89216 | INJECTIO PROCAIN.CHLOR.1% ARD | inj 1x200ml 1% | ARD | CZ | | | | | 89217 | INJECTIO PROCAIN.CHLOR.1% ARD | inj 20x200ml 1% | ARD | CZ | | | | | 01691 | PROCAINII HYDROCHL.0.2% MEDVIR | inj 1x200ml | VYS | CZ | | | | | 365 | N01BB | lokální anestetika ze skupiny amidů | lok. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 365.1 | N01BB | trimekain | lok. | 1 | GM | 1,25 | O | | 02684 | MESOCAIN | gel 1x20gm | SLO | SK | | | | | 365.2 | N01BB02 | lidokain | lok. | 1 | ML | 8,95 | O | | 62393 | INSTILLAGEL | gel 10x11ml(strik.) | FAP | D | | | | | 62392 | INSTILLAGEL | gel 10x6ml(strik.) | FAP | D | | | | | 365.3 | N01BB02 | lidokain (lékové formy spreje, koncentrace 10%) | lok. | 1 | GM | 2,15 | O | | 366 | N01BB | lokální anestetika ze skupiny amidů | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 366.1 | N01BB | trimekain (koncentrace 0,5%) | parent. | 1 | ML | 0,70 | O | | 69704 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1x80ml 0.5% | ARD | CZ | | | | | 69705 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1x250ml 0.5% | ARD | CZ | | | | | 69706 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1x500ml 0.5% | ARD | CZ | | | | | 86452 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 40x80ml 0.5% | ARD | CZ | | | | | 86453 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 20x250ml 0.5% | ARD | CZ | | | | | 86454 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 12x500ml 0.5% | ARD | CZ | | | | | 366.2 | N01BB | trimekain (koncentrace 1%, do 10 ml v jedné ampuli včetně) | parent. | 1 | ML | 1,40 | O | | 00502 | MESOCAIN | inj 10x10ml 1% | LEX | CZ | | | | | 366.3 | N01BB | trimekain (koncentrace 1%, nad 10 ml v jedné ampuli) | parent. | 1 | ML | 0,75 | O | | 69707 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1x80ml 1% | ARD | CZ | | | | | 69708 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1x250ml 1% | ARD | CZ | | | | | 69709 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1x500ml 1% | ARD | CZ | | | | | 86455 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 40x80ml 1% | ARD | CZ | | | | | 86456 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 20x250ml 1% | ARD | CZ | | | | | 86457 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 12x500ml 1% | ARD | CZ | | | | | 366.4 | N01BB | trimekain (koncentrace 2%) | parent. | 1 | ML | 1,25 | O | | 00503 | MESOCAIN | inj 10x5ml 2% | LEX | CZ | | | | | 366.5 | N01BB | trimekain/adrenalin | parent. | 1 | ML | 2,40 | O | | | | | | | | | | | 366.6 | N01BB01 | bupivakain | parent. | 1 | ML | 3,60 | O | | | | | | | | | | | 366.7 | N01BB01 | bupivakain (lékové formy spinal) | parent. | 1 | ML | 51,40 | O | | | | | | | | | | | 366.8 | N01BB02 | lidokain | parent. | 1 | ML | 1,25 | O | | | | | | | | | | | 366.9 | N01BB03 | mepivakain | parent. | 1 | ML | 3,60 | O | | | | | | | | | | | 366.10 | N01BB08 | artikain | parent. | 1 | ML | 4,25 | O | | 366.11 | N01BB08 | artikain (lékové formy hyperbar) | parent. | 1 | ML | 10,45 | O | | 91234 | ULTRACAIN HYPERBAR 5% | inj 10x2ml/100mg | HOE | D | | | | | 366.12 | N01BB51 | bupivakain/adrenalin | parent. | 1 | ML | 3,90 | O | | | | | | | | | | | 366.13 | N01BB52 | lidokain/adrenalin | parent. | 1 | ML | 2,40 | O | | | | | | | | | | | 366.14 | N01BB58 | artikain/adrenalin | parent. | 1 | ML | 4,25 | O | | 93109 | SUPRACAIN 4% | inj 10x2ml | LEX | CZ | | | | | 87571 | ULTRACAIN 2% | inj 5x5ml | HOE | D | | | | | 367 | N01BX | ostatní lokální anestetika | lok. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 367.1 | N01BX01 | ethylchlorid | lok. | 100 | ML | 95,50 | O | | 02088 | CHLORAETHYL | spr 1x100ml | LZK | CZ | | | | | 368 | N02AA | analgetika ze skupiny přírodních opioidů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 368.1 | N02AA01 | morfin (do 10 mg v jedné tabletě včetně) | p.o. | 0.1 | GM | 100,00 | | | 94309 | MST CONTINUS | tbl 60x10mg | NPP | GB | | | | | 80405 | VENDAL RETARD | tbl fc 30x10mg | LAR | D | | | | | 368.2 | N02AA01 | morfin (od 10 mg do 100 mg v jedné tabletě) | p.o. | 0.1 | GM | 67,00 | | | 94311 | MST CONTINUS | tbl 60x60mg | NPP | GB | | | | | 94310 | MST CONTINUS | tbl 60x30mg | NPP | GB | | | | | 80406 | VENDAL RETARD | tbl fc 30x30mg | LAR | D | | | | | 80407 | VENDAL RETARD | tbl fc 30x60mg | LAR | D | | | | | 368.3 | N02AA01 | morfin (100 a více mg v jedné tabletě) | p.o. | 0.1 | GM | 63,00 | | | 94312 | MST CONTINUS | tbl 60x100mg | NPP | GB | | | | | 80409 | VENDAL RETARD | tbl fc 30x200mg | LAR | D | | | | | 80408 | VENDAL RETARD | tbl fc 30x100mg | LAR | D | | | | | 368.4 | N02AA08 | dihydrocodein (do 90 mg v jedné tabletě včetně) | p.o. | 0.24 | GM | 59,30 | | | 80451 | DHC CONTINUS 60MG | tbl 56x60mg | NPP | GB | | | | | 80452 | DHC CONTINUS 90MG | tbl 56x90mg | NPP | GB | | | | | 368.5 | N02AA08 | dihydrocodein (nad 90 mg v jedné tabletě) | p.o. | 0.24 | GM | 50,50 | | | 80453 | DHC CONTINUS 120MG | tbl 56x120mg | NPP | GB | | | | | 369 | N02AA | analgetika ze skupiny přírodních opioidů | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 369.1 | N02AA01 | morfin (do 10 mg v jedné ampuli včetně) | parent. | 30 | MG | 16,35 | O | | 01125 | MORPHIN BIOTIKA 1% | inj 10x1ml/10mg | HBS | SK | | | | | 369.2 | N02AA01 | morfin (nad 10 mg v jedné ampuli) | parent. | 30 | MG | 9,90 | O | | 01127 | MORPHIN BIOTIKA 1% | inj 10x2ml/20mg | HBS | SK | | | | | 370 | N02AB | analgetika ze skupiny fenylpiperidinových derivátů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 370.1 | N02AB02 | pethidin | p.o. | 0.4 | GM | 42,25 | | | 01116 | DOLSIN | gtt 1x10ml/500mg | SLO | SK | | | | | 370.2 | N02AB03 | fentanyl (s řízeným uvolňováním 2,5 mikrogramu z 1 cm2 za hodinu) | transd. | 1 | CM2 | 21,50 | |
Lék je aplikován v případech, kdy pacient není schopen perorálního příjmu opioidů.
Čtení tohoto dokumentu nenahrazuje čtení příslušného vydání Sbírky zákonů. Neneseme odpovědnost za případné nepřesnosti vyplývající z převodu originálu do tohoto formátu.
Tento text je zveřejněn za vlastních podmínek opětovného použití zdroje e-Sbírka, nikoli pod licencí Legalize ani pod licencí volného díla.
e-Sbírka
volné dílo (úřední díla podle § 3 písm. a) zákona č. 121/2000 Sb., autorského zákona)